Page 195 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 195

Disorders of Calcium: Hypercalcemia and Hypocalcemia  185



            265. Hristova EN, Cecco S, Niemela JE, et al. Analyzer-depen-  for hypercalcemia of malignancy. J Am Anim Hosp Assoc
                dent  differences  in  results  for  ionized  calcium,  2004;40:75–81.
                ionized magnesium, sodium, and pH. Clin Chem    284. Kalantar-Zadeh K, Kovesdy CP. Is it worth correcting
                1995;41:1649–53.                                     hyperparathyroidism if hyperphosphatemia and hypocal-
            266. Hsu CH, Patel SR. Altered vitamin D metabolism and  cemia worsen? A Cinacalcet story. Am J Kidney Dis
                receptor interaction with the target genes in renal failure:  2009;53:183–8.
                calcitriol receptor interaction with its target gene in renal  285. Kallet AJ, Richter KP, Feldman EC, et al. Primary hyper-
                failure. Curr Opin Nephrol Hypertens 1995;4:302–6.   parathyroidism in cats: seven cases (1984-1989). J Am
            267. Hulter HN, Halloran BP, Toto RD, et al. Long-term con-  Vet Med Assoc 1991;199:1767–71.
                trol of plasma calcitriol concentration in dogs and  286. Kallfelz FA. Nutritional supplements in small animal prac-
                humans: dominant role of plasma calcium concentration  tice: boon or bane? In: Proceedings of the 8th Am Coll
                in experimental hyperparathyroidism. J Clin Invest   Vet Intern Med Forum. Washington, DC; 1990.
                1985;76:695–702.                                287. Karaplis AC, Luz A, Glowacki J, et al. Lethal skeletal
            268. Hume DZ, Drobatz KJ, Hess RS. Outcome of dogs with  dysplasia from targeted disruption of the parathyroid
                diabetic ketoacidosis: 127 dogs (1993-2003). J Vet Intern  hormone-related  peptide  gene.  Genes  Dev
                Med 2006;20(3):547–55.                               1994;8:277–89.
            269. Hung SH, Tsai WY, Tsao PN, et al. Oral clodronate ther-  288. Kasahara H, Tsuchiya M, Adachi R, et al. Development
                apy for hypercalcemia related to extensive subcutaneous  of a C-terminal-region-specific radioimmunoassay of
                fat necrosis in a newborn. J Formos Med Assoc        parathyroid hormone-related protein. Biomed Res
                2003;102:801–4.                                      1992;13:155–61.
            270. Hutson CA, Willauer CC, Walder EJ, et al. Treatment of  289. Kawaguchi K, Braga 3rd IS, Takahashi A, et al. Nutritional
                mandibular squamous cell carcinoma in cats by use of  secondary hyperparathyroidism occurring in a strain of
                mandibulectomy and radiotherapy: seven cases (1987-  German shepherd puppies. Jpn J Vet Res 1993;41:89–96.
                1989). J Am Vet Med Assoc 1992;201:777–81.      290. Kawasaki T. Creatinine unreliable indicator of renal failure
            271. Ihle SL, Nelson RW, Cook Jr JR. Seizures as a manifesta-  in ferrets. J Small Anim Exotic Med 1991;1:28–9.
                tion of primary hyperparathyroidism in a dog. J Am Vet  291. Kestenbaum B, Sampson JN, Rudser KD, et al. Serum
                Med Assoc 1988;192:71–2.                             phosphate levels and mortality risk among people
            272. Imaizumi T, Tsuruta M, Kitagaki T, et al. Single dose  with chronic kidney disease. J Am Soc Nephrol
                toxicity studies of calcipotriol (MC903) in rats and dogs.  2005;16:520–8.
                J Toxicol Sci 1996;21(Suppl. 2):277–85.         292. Khosla S, van Heerden JA, Gharib H, et al. Parathyroid
            273. Imaizumi T, Tsuruta M, Koike Y, et al. A 26-week repeated  hormone-related protein and hypercalcemia secondary
                percutaneous dose toxicity study of calcipotriol (MC903)  to massive mammary hyperplasia. N Engl J Med
                in dogs. J Toxicol Sci 1996;21(Suppl. 2):365–87.     1990;322:1157.
            274. Imaizumi T, Tsuruta M, Koike Y, et al. A 4-week repeated  293. Kifor O, McElduff A, LeBoff MS, et al. Activating
                percutaneous dose toxicity study of calcipotriol (MC903)  antibodies to the calcium-sensing receptor in two patients
                followed by a 4-week recovery test in dogs. J Toxicol Sci  with autoimmune hypoparathyroidism. J Clin Endocrinol
                1996;21(Suppl. 2):309–23.                            Metab 2004;89:548–56.
            275. Imamura H, Sato K, Shizume K, et al. Urinary excretion  294. Kimmel SE, Waddell LS, Michel KE. Hypomagnesemia
                of parathyroid hormone-related protein fragments in  and hypocalcemia associated with protein-losing enterop-
                patients with humoral hypercalcemia of malignancy and  athy in Yorkshire terriers: five cases (1992-1998). J Am
                hypercalcemic tumor-bearing nude mice. J Bone Miner  Vet Med Assoc 2000;217:703–6.
                Res 1991;6:77–84.                               295. Kimmel SE, Washabau RJ, Drobatz KJ. Incidence and
            276. Irvine RF. Calcium transients: mobilization of intracellu-  prognostic value of low plasma ionized calcium concentra-
                lar Ca . Br Med Bull 1986;42:369–74.                 tion in cats with acute pancreatitis: 46 cases (1996-1998).
                     2þ
            277. Izquierdo R, Bermes Jr E, Sandberg L, et al. Serum cal-  J Am Vet Med Assoc 2001;219:1105–9.
                cium metabolism in acute experimental pancreatitis. Sur-  296. Kirby R, Iverson W, Schaer M. Hypercalcemic nephropa-
                gery 1985;98:1031–7.                                 thy in a young dog resembling human milk alkali syn-
            278. Jackson IT, Saleh J, van Heerden JA. Gigantic mammary  drome. J Am Anim Hosp Assoc 1992;28:119–23.
                hyperplasia in pregnancy associated with pseudohyperpar-  297. Kirk GR, Breazile JE, Kenny AD. Pathogenesis of hypo-
                athyroidism. Plast Reconstr Surg 1989;84:806–10.     calcemic tetany in the thyroparathyroidectomized dog.
            279. John MR, Goodman WG, Gao P, et al. A novel          Am J Vet Res 1974;35:407–8.
                immunoradiometric assay detects full-length human  298. Kiupel M, Teske E, Bostock D. Prognostic factors for
                PTH but not amino-terminally truncated fragments:    treated  canine  malignant  lymphoma.  Vet  Pathol
                implications for PTH measurements in renal failure. J Clin  1999;36:292–300.
                Endocrinol Metab 1999;84:4287–90.               299. Klausner JS, Bell FW, Hayden DW, et al. Hypercalcemia in
            280. Jono S, McKee MD, Murry CE, et al. Phosphate regula-  two cats with squamous cell carcinomas. J Am Vet Med
                tion of vascular smooth muscle cell calcification. Circ Res  Assoc 1990;196:103–5.
                2000;87:e10–7.                                  300. Klausner JS, Fernandez FR, O’Leary TP, et al. Canine
            281. Jorgensen LS, Center SA, Randolph JF, et al. Electrolyte  primary hyperparathyroidism and its association with
                abnormalities induced by hypertonic phosphate enemas in  urolithiasis. Vet Clin North Am Small Anim Pract
                two cats. J Am Vet Med Assoc 1985;187:1367–8.        1986;16:227–39.
            282. Jutkowitz LA, Rozanski EA, Moreau JA, et al. Massive  301. Klein MK, Powers BE, Withrow SJ, et al. Treatment of thy-
                transfusion in dogs: 15 cases (1997-2001). J Am Vet  roid carcinoma in dogs by surgical resection alone: 20 cases
                Med Assoc 2002;220:1664–9.                           (1981-1989). J Am Vet Med Assoc 1995;206:1007–9.
            283. Kadar E, Rush JE, Wetmore L, et al. Electrolyte  302. Knecht TP, Behling CA, Burton DW, et al. The humoral
                disturbances and cardiac arrhythmias in a dog following  hypercalcemia of benignancy: a newly appreciated
                pamidronate, calcitonin, and furosemide administration  syndrome. Am J Clin Pathol 1996;105:487–92.
   190   191   192   193   194   195   196   197   198   199   200